With base in Taiwan, BioLite not only intergrates diverse expertise from local biotech companies and research institutes, but also establishes partnerships globally. We actively search for and evaluate innovative proprietary technology with market potential to develope. BioLite focuses on performance, results, and risk management to maximize our shareholders' return, which is our No.1 corporate objective.

BioLite has well-designed Internal Audit and Internal Control Systems which meets government regulatory requirements. This prepares us to enter the public market.

Beside new drug development, BioLite also extends its business to the fast-growing health management industry. Established in 2013, BioLite Healthcare Center integrates preventive medicine and genetic tests. BioLite is also distributing high quality and unique dietary supplements from all over the world.